Resmed (RSMDF) Cash from Operations Growth (1y) (2010 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | -12.60% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | -15.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.62% |
| Mar 31, 2026 | -4.24% |
| Dec 31, 2025 | 10.08% |
| Sep 30, 2025 | 40.48% |
| Jun 30, 2025 | 22.42% |
| Mar 31, 2025 | 43.93% |
| Dec 31, 2024 | 13.12% |
| Sep 30, 2024 | 13.71% |
| Jun 30, 2024 | 85.36% |
| Mar 31, 2024 | 42.28% |
| Dec 31, 2023 | 112.10% |
| Sep 30, 2023 | 541.00% |
| Jun 30, 2023 | 198.71% |
| Mar 31, 2023 | 140.61% |
| Dec 31, 2022 | -41.50% |
| Sep 30, 2022 | 168.02% |
| Jun 30, 2022 | -64.91% |
| Mar 31, 2022 | -40.17% |
| Dec 31, 2021 | 29.40% |
| Sep 30, 2021 | -145.60% |